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The structure of the title compound, C8H9N3, a potential
antitumour drug, was determined in order to give more insight
into its structure–function relationships. The benzimidazole
core of the molecule was found to be exactly planar, while the
substituents are displaced slightly from the molecular plane
[C—C—N—C and C—C—C—N torsion angles of 0.8 (3) and
179.0 (1)  for the methyl and amino groups, respectively]. The
bond lengths are analysed in detail and compared with those
of the parent unsubstituted analogues. The results show that
the lone-pair electrons on the amino N atom are involved in
conjugation with the adjacent   system and hence affect the
charge distribution inthe heterocycle. Two intermolecular N—
H   N and C—H   N hydrogen bonds have been identiﬁed.
Related literature
For the synthesis, see: Milata et al. (1989). For bond-order–
bond-length curves, see: Burke-Laing & Laing (1976). For the
biological activity of benzimidazole derivatives, see: Kettmann
et al. (2004); Le et al. (2004); Nguyen et al. (2004); Statkova-
Abeghe et al. (2005). For a description of the Cambridge
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Table 1
Hydrogen-bond geometry (A ˚ ,  ).
D—H   AD —H H   AD    AD —H   A
N5—H5A   N3
i 0.86 2.47 3.1447 (19) 136
C2—H2   N5
ii 0.93 2.58 3.503 (2) 171
Symmetry codes: (i)  x þ 1
2;y   1
2; z þ 1
2; (ii) x þ 1
2; y þ 1
2;z þ 1
2.
Data collection: CrysAlis CCD (Oxford Diffraction, 2009); cell
reﬁnement: CrysAlis RED (Oxford Diffraction, 2009); data reduc-
tion: CrysAlis RED; program(s) used to solve structure: SHELXS97
(Sheldrick, 2008); program(s) used to reﬁne structure: SHELXL97
(Sheldrick, 2008); molecular graphics: ORTEP-3 (Farrugia, 1997);
software used to prepare material for publication: enCIFer (Allen et
al., 2004).
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5-Amino-1-methyl-1H-benzimidazole
J. Lokaj, V. Kettmann, V. Milata and T. Solcan
Comment
Benzimidazole derivatives are known to possess a variety of biological properties (Le et al., 2004), the anti-cancer activity
being one of the most important (Nguyen et al., 2004). Previously, it was shown that (a) introduction of a small substituent
to the benzo-ring of 1H-benzimidazoles has a profound effect on the cytotoxic activity (Statkova-Abeghe et al., 2005) and
(2) the activity is related to intercalative interaction of the drug molecule with the nuclear DNA or the DNA-topoisomerase
binary complex (Kettmann et al., 2004). It is, however, unclear whether the influence of the substituents reflects their effect
on the charge distribution of the heterocycle (and hence the intercalative energy) or results from interaction of the substituents
with additional DNA or enzyme functionalities. Consequently, we prepared a series of substituted 1-methylbenzimidazoles
and determined and compared their molecular and electronic structures by using theoretical and experimental techniques.
In this communication we report the crystal structure of the 5-amino derivative, (I).
As expected, the ring system of the molecule is planar (Fig.1) to within experimental error and the substituents are
slightly displaced to the same side of the plane, as indicated by torsion angles of 0.8 (3)° (C7-C8-N1-C10) and 179.0 (1)°
(C9-C4-C5-N5) for the methyl and amino groups, respectively.
As mentioned above, the main purpose of this work was to compare precise molecular dimensions in the present deriv-
ative, (I), with those of the unsubstituted 1-methylbenzimidazole. As the latter compound has no entry in the Cambridge
Structural Database (CSD, version 5.30 of November 2008; Allen, 2002), the CSD was searched for compounds possessing
the benzimidazole core and just one substituent with the methylene group in the α-position; 42 such compounds [hereafter
(II)] were found. The comparison has shown that the corresponding bond lengths in the benzimidazole heterocycle in (I) and
in the molecules of (II) are significantly different. More specifically, the corresponding bond lengths are [the first number
concerns compound (I), second number represents an average through 42 compounds (II)]: C4—C5: 1.382 (2), 1.355 (3);
C5—C6: 1.410 (2), 1.387 (3); C6—C7: 1.370 (2), 1.387 (3); C7—C8: 1.391 (2), 1.370 (3); C8—C9: 1.393 (2), 1.397 (2);
C9—C4: 1.389 (2), 1.403 (3) Å. This, along with the partial double-bond character of C5–N5 (according to the bond-order
- bond-length curves proposed by Burke-Laing & Laing, 1976) indicates that the amino group is conjugated with the benzi-
midazole ring. This further implies that for the present derivative the intercalative energy makes an important contribution to
the overall drug-DNA binding energy and hence the enhanced cytotoxic activity of (I) relative to (II) (Kettmann et al., 2004).
These results will serve as a basis for subsequent molecular-modelling studies of the DNA-enzyme-ligand interactions.
The crystal packing is dominated by two intermolecular N–H···N and C–H···N hydrogen bonds (Table 1). It is notable that
the amino N5 atom accepts a (weak) hydrogen bond but only one of the two N–H donors is involved in hydrogen bonding.
Experimental
As described in detail previously (Milata et al., 1989), the title compound, (I), was synthesized by starting from 2,4-dinitro-
chlorobenzene via nucleophilic substitution of the chlorine with methylamine, followed by partial Zinnin reduction of thesupplementary materials
sup-2
ortho-nitro group and subsequent cyclization to obtain 1-methyl-5-nitrobenzimidazole which after reduction gives the target
compound (m.p. 430–432 K).
Refinement
H atoms were visible in difference maps and were subsequently treated as riding atoms with distances C—H = 0.93 Å
(CHarom), 0.96 Å (CH3) and N—H = 0.86 Å; Uiso of the H atoms were set to 1.2 (1.5 for the methyl H atoms) times Ueq
of the parent atom.
Figures
Fig. 1. Perspective view of (I), with the atom numbering scheme. Thermal ellipsoids are
drawn at the 50% probability level.
5-Amino-1-methyl-1H-benzimidazole
Crystal data
C8H9N3 F000 = 312
Mr = 147.18 Dx = 1.283 Mg m−3
Monoclinic, P21/n Melting point: 431 K
Hall symbol: -P 2yn Mo Kα radiation, λ = 0.71073 Å
a = 5.9128 (2) Å Cell parameters from 7029 reflections
b = 8.8215 (3) Å θ = 3.5–29.5º
c = 14.8418 (6) Å µ = 0.08 mm−1
β = 100.129 (3)º T = 296 K
V = 762.08 (5) Å3 Needle, orange
Z = 4 0.52 × 0.20 × 0.10 mm
Data collection
Oxford Diffraction Gemini R CCD
diffractometer
1832 independent reflections
Radiation source: fine-focus sealed tube 1114 reflections with I > 2σ(I)
Monochromator: graphite Rint = 0.039
Detector resolution: 10.434 pixels mm-1 θmax = 28.0º
T = 296 K θmin = 3.5º
ω scans h = −7→7
Absorption correction: analytical
[CrysAlis RED (Oxford Diffraction, 2009) based on
Clark & Reid (1995)]
k = −11→11
Tmin = 0.944, Tmax = 0.966 l = −19→19
18508 measured reflectionssupplementary materials
sup-3
Refinement
Refinement on F2 Secondary atom site location: difference Fourier map
Least-squares matrix: full Hydrogen site location: inferred from neighbouring
sites
R[F2 > 2σ(F2)] = 0.046 H-atom parameters constrained
wR(F2) = 0.141
  w = 1/[σ2(Fo
2) + (0.086P)2]
where P = (Fo
2 + 2Fc
2)/3
S = 1.02 (Δ/σ)max = 0.001
1832 reflections Δρmax = 0.21 e Å−3
101 parameters Δρmin = −0.21 e Å−3
Primary atom site location: structure-invariant direct
methods Extinction correction: none
Special details
Experimental. Analytical numeric absorption correction using a multifaceted crystal model based on expressions derived by Clark &
Reid (1995).
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance mat-
rix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations
between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of
cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Least-squares planes (x,y,z in crystal coordinates) and deviations from them (* indicates atom used to define plane)
2.7140 (0.0026) x - 6.5500 (0.0019) y + 5.9298 (0.0054) z = 1.2109 (0.0022)
* -0.0006 (0.0010) N1 * -0.0119 (0.0012) C2 * -0.0077 (0.0011) N3 * 0.0063 (0.0010) C4 * -0.0054 (0.0011) C5 * -0.0129
(0.0011) C6 * 0.0007 (0.0011) C7 * 0.0188 (0.0012) C8 * 0.0127 (0.0012) C9 - 0.0337 (0.0017) N5 - 0.0311 (0.0023) C10
Rms deviation of fitted atoms = 0.0103
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, convention-
al R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-
factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large
as those based on F, and R- factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x y z Uiso*/Ueq
N1 −0.0430 (2) 0.25393 (13) 0.50429 (8) 0.0589 (4)
C2 0.1513 (3) 0.32925 (18) 0.49663 (12) 0.0677 (5)
H2 0.2202 0.3987 0.5401 0.081*
N3 0.2352 (2) 0.29646 (15) 0.42273 (9) 0.0675 (4)
C4 0.0831 (2) 0.11583 (16) 0.29522 (9) 0.0546 (4)
H4 0.1996 0.1333 0.2618 0.066*
C5 −0.0929 (2) 0.01590 (15) 0.26336 (10) 0.0561 (4)
N5 −0.1043 (2) −0.05967 (15) 0.18037 (9) 0.0746 (4)supplementary materials
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H5A −0.0002 −0.0447 0.1475 0.090*
H5B −0.2155 −0.1214 0.1619 0.090*
C6 −0.2678 (2) −0.00852 (17) 0.31522 (11) 0.0646 (5)
H6 −0.3861 −0.0754 0.2930 0.077*
C7 −0.2698 (2) 0.06273 (17) 0.39712 (12) 0.0634 (4)
H7 −0.3862 0.0452 0.4306 0.076*
C8 −0.0905 (2) 0.16230 (15) 0.42807 (9) 0.0509 (4)
C9 0.0833 (2) 0.18977 (15) 0.37784 (10) 0.0512 (4)
C10 −0.1765 (3) 0.2690 (2) 0.57695 (12) 0.0796 (5)
H10A −0.0975 0.3348 0.6237 0.119*
H10B −0.1962 0.1711 0.6027 0.119*
H10C −0.3243 0.3112 0.5525 0.119*
Atomic displacement parameters (Å2)
U11 U22 U33 U12 U13 U23
N1 0.0648 (8) 0.0597 (7) 0.0537 (8) 0.0113 (6) 0.0147 (6) 0.0011 (6)
C2 0.0660 (10) 0.0668 (9) 0.0681 (11) 0.0043 (8) 0.0053 (8) −0.0118 (8)
N3 0.0594 (7) 0.0701 (8) 0.0745 (9) −0.0073 (6) 0.0156 (6) −0.0147 (7)
C4 0.0524 (7) 0.0571 (8) 0.0564 (9) 0.0039 (6) 0.0155 (6) 0.0016 (7)
C5 0.0588 (8) 0.0517 (8) 0.0554 (9) 0.0108 (6) 0.0037 (6) −0.0003 (6)
N5 0.0777 (9) 0.0769 (9) 0.0664 (9) 0.0007 (7) 0.0047 (7) −0.0173 (7)
C6 0.0566 (8) 0.0562 (9) 0.0806 (12) −0.0067 (7) 0.0115 (8) −0.0060 (8)
C7 0.0562 (8) 0.0606 (9) 0.0779 (11) −0.0014 (7) 0.0243 (7) 0.0048 (8)
C8 0.0541 (8) 0.0483 (7) 0.0513 (8) 0.0090 (6) 0.0116 (6) 0.0050 (6)
C9 0.0465 (7) 0.0493 (7) 0.0580 (8) 0.0032 (6) 0.0099 (6) −0.0005 (6)
C10 0.0964 (12) 0.0869 (12) 0.0616 (10) 0.0198 (9) 0.0307 (9) 0.0024 (9)
Geometric parameters (Å, °)
N1—C2 1.350 (2) N5—H5A 0.8600
N1—C8 1.3785 (18) N5—H5B 0.8600
N1—C10 1.450 (2) C6—C7 1.370 (2)
C2—N3 1.313 (2) C6—H6 0.9300
C2—H2 0.9300 C7—C8 1.391 (2)
N3—C9 1.3879 (19) C7—H7 0.9300
C4—C5 1.382 (2) C8—C9 1.3926 (19)
C4—C9 1.3888 (19) C10—H10A 0.9600
C4—H4 0.9300 C10—H10B 0.9600
C5—N5 1.3917 (19) C10—H10C 0.9600
C5—C6 1.410 (2)
C2—N1—C8 105.84 (12) C7—C6—H6 118.8
C2—N1—C10 126.90 (14) C5—C6—H6 118.8
C8—N1—C10 127.25 (14) C6—C7—C8 117.22 (13)
N3—C2—N1 114.48 (14) C6—C7—H7 121.4
N3—C2—H2 122.8 C8—C7—H7 121.4
N1—C2—H2 122.8 N1—C8—C7 132.41 (13)
C2—N3—C9 104.04 (12) N1—C8—C9 105.93 (12)supplementary materials
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C5—C4—C9 119.04 (13) C7—C8—C9 121.62 (13)
C5—C4—H4 120.5 N3—C9—C4 129.96 (12)
C9—C4—H4 120.5 N3—C9—C8 109.71 (12)
C4—C5—N5 121.66 (14) C4—C9—C8 120.32 (13)
C4—C5—C6 119.40 (14) N1—C10—H10A 109.5
N5—C5—C6 118.93 (14) N1—C10—H10B 109.5
C5—N5—H5A 120.0 H10A—C10—H10B 109.5
C5—N5—H5B 120.0 N1—C10—H10C 109.5
H5A—N5—H5B 120.0 H10A—C10—H10C 109.5
C7—C6—C5 122.39 (14) H10B—C10—H10C 109.5
C8—N1—C2—N3 0.28 (18) C10—N1—C8—C9 178.60 (13)
C10—N1—C2—N3 −178.55 (14) C6—C7—C8—N1 177.97 (14)
N1—C2—N3—C9 −0.21 (18) C6—C7—C8—C9 0.5 (2)
C9—C4—C5—N5 178.96 (12) C2—N3—C9—C4 178.98 (14)
C9—C4—C5—C6 0.1 (2) C2—N3—C9—C8 0.05 (17)
C4—C5—C6—C7 −0.5 (2) C5—C4—C9—N3 −178.28 (14)
N5—C5—C6—C7 −179.37 (13) C5—C4—C9—C8 0.6 (2)
C5—C6—C7—C8 0.2 (2) N1—C8—C9—N3 0.11 (16)
C2—N1—C8—C7 −177.99 (16) C7—C8—C9—N3 178.17 (13)
C10—N1—C8—C7 0.8 (3) N1—C8—C9—C4 −178.94 (11)
C2—N1—C8—C9 −0.23 (15) C7—C8—C9—C4 −0.9 (2)
Hydrogen-bond geometry (Å, °)
D—H···A D—H H···A D···A D—H···A
N5—H5A···N3i 0.86 2.47 3.1447 (19) 136
C2—H2···N5ii 0.93 2.58 3.503 (2) 171
Symmetry codes: (i) −x+1/2, y−1/2, −z+1/2; (ii) x+1/2, −y+1/2, z+1/2.supplementary materials
sup-6
Fig. 1